Docket Room.
SR 201·KY·senate

A RESOLUTION encouraging Kentucky policymakers to study, develop, and implement economic development policies to incentivize biopharmaceutical investment and innovation in Kentucky.

AdoptedFiled Mar 26, 2026
Sponsor: Shelley Frommeyer (R)
Latest Action

adopted by voice vote

Apr 1, 2026

Email me when SR 201 moves

Committee action, floor votes, amendments and hearings. Free, no card, no password.

Already have an account? Track SR 201. By continuing you agree to the Terms and Privacy Policy.

Legislative status

  1. Introduced
  2. In Committee
  3. Reported by Committee
  4. Floor Vote Scheduled
  5. Passed One Chamber
  6. Passed Both Chambers
  7. Adopted

Summary

The Senate passed a resolution encouraging state policymakers to examine, design, and adopt economic policies that would attract biopharma companies to Kentucky. It highlights the potential for high‑paying jobs and urges incentives such as tax credits, grants, and dedicated funding pools. The measure is symbolic, aiming to keep talent and research in the state.

AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.

Ask about SR 201

3 free questions a day, no account

History

  1. adopted by voice vote
  2. to Senate Floor
  3. to Committee on Committees (S)
  4. introduced in Senate

Sponsors

  • Shelley Frommeyer (R) · sponsor
  • R. Stivers
  • S. Funke Frommeyer

Bill text

Read the official text ↗

Opens the legislature’s own copy.

Similar bills in other states

Loading the map of where bills like this one were filed.

Share

Writing about this bill? Add a live status widget to your site or newsletter. It updates as the bill moves.

Track this bill

Get an email when SR 201 moves: committee action, floor votes, amendments and hearings. Free, no card.

Track SR 201 free

Or ask your AI assistant about SR 201 directly:

Add to Claude, ChatGPT or Cursor
Docket Room · Nonpartisan legislative tracking
Docket Room IntelligencePro

Ask about your legislation

I can analyze your tracked bills, upcoming hearings, and recent changes.

AI-generated · Nonpartisan · Not legal advice